Target intelligence / Profile preview

MEIS1 antisense RNA 3 (MEIS1-AS3)

Target
MEIS1-AS3
Molecular classification
Long non-coding RNA (lncRNA), Non-coding RNA
01

Overview

MEIS1 antisense RNA 3 (MEIS1-AS3) is a long non-coding RNA transcribed from the MEIS1 gene region. Its functional characterization remains limited. Like other antisense lncRNAs, MEIS1-AS3 is presumed to regulate the expression of its sense gene partner (MEIS1), which encodes a Homeobox transcription factor critical in hematopoiesis, cell cycle progression, development, and several malignancies[1][3]. There is no established role for MEIS1-AS3 as a direct therapeutic target, nor is it currently considered a biomarker or drug target. MEIS1-AS3 appears in gene databases such as BioGPS as a bona fide, non-coding RNA gene (NCBI Gene ID 730198)[3]. The biological and therapeutic relevance of MEIS1 arises mainly via its role as a transcription factor, which is influenced by complex regulatory mechanisms including lncRNAs and microRNAs. Some studies discuss lncRNAs and ncRNAs in regulating MEIS1, but MEIS1-AS3 specifically has not yet emerged as a major actor or target in disease or therapy[1][2]. No drugs or direct molecular interventions currently target MEIS1-AS3.

02

Mechanism of action

Not applicable; there are no reported drugs targeting this lncRNA.

03

Biological functions

Regulation of gene expression (specifically, regulation of the MEIS1 locus)
04

Disease associations

Other (Potential indirect involvement in cancer, depending on its regulatory effect on MEIS1)

Beyond the preview

Go deeper on MEIS1 antisense RNA 3 (MEIS1-AS3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MEIS1 antisense RNA 3 (MEIS1-AS3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call